{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T02:10:52Z","timestamp":1724379052126},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bulcan.2015.11.010","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T21:47:11Z","timestamp":1453758431000},"page":"164-172","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancers du col ut\u00e9rin de stade IB2, IIA et IIB sans extension ganglionnaire trait\u00e9s par chimioradioth\u00e9rapie pr\u00e9op\u00e9ratoire"],"prefix":"10.1016","volume":"103","author":[{"given":"Laurie","family":"Monnier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Pierre","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Lauratet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.11.010_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0167-8140(92)90337-T","article-title":"Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix\u2013the Villejuif experience, 1975\u20131984","volume":"23","author":"Gerbaulet","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0167-8140(95)01535-O","article-title":"Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis","volume":"35","author":"Fyles","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0360-3016(97)00145-4","article-title":"Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors","volume":"38","author":"Barillot","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0360-3016(98)00067-4","article-title":"Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix","volume":"41","author":"Perez","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0190","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18\u00a0randomized trials","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02\u00a0study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2\u00a0or II cervical cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0200","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ygyno.2005.08.047","article-title":"Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma","volume":"100","author":"Houvenaeghel","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.canrad.2009.04.001","article-title":"Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience","volume":"13","author":"Kirova","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canrad.2004.02.002","article-title":"Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion","volume":"8","author":"Lerouge","year":"2004","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0220","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ijrobp.2008.03.054","article-title":"Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion","volume":"72","author":"Huguet","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0225","series-title":"Dose and volume specification for intracavitary therapy in gynecology: ICRU Report 38","author":"ICRU","year":"1985"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0230","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"Piver","year":"1974","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1525-1438.2001.011004263.x","article-title":"A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment","volume":"11","author":"Narayan","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0240","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1200\/JCO.2007.14.3933","article-title":"Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2\/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area","volume":"26","author":"Boughanim","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0245","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cncr.25739","article-title":"Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography\/computed tomography findings","volume":"117","author":"Ramirez","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0250","first-page":"1661","article-title":"The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer","volume":"33","author":"Chereau","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/gyno.1994.1168","article-title":"Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma","volume":"54","author":"Resbeut","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0260","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2006.01.022","article-title":"Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)","volume":"102","author":"Classe","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.2009-0295","article-title":"Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer","volume":"15","author":"Touboul","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/COC.0b013e3182610537","article-title":"ACR Appropriateness Criteria(R) definitive therapy for early-stage cervical cancer","volume":"35","author":"Small","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0275","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2006.05.039","article-title":"Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery","volume":"66","author":"Nijhuis","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0285","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.23817","article-title":"Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2\/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results","volume":"113","author":"Vincens","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0290","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cncr.26317","article-title":"Can radicality of surgery be safely modulated on the basis of MRI and PET\/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?","volume":"118","author":"Ferrandina","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-8258(03)00173-2","article-title":"Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group","volume":"89","author":"Keys","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0300","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canrad.2012.02.002","article-title":"Dosimetric comparison between the intensity modulated radiotherapy with fixed field and Rapid Arc of cervix cancer","volume":"16","author":"Renard-Oldrini","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0310","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2015.11.010_bib0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semradonc.2011.12.009","article-title":"Biological predictors of cervical cancer response to radiation therapy","volume":"22","author":"Klopp","year":"2012","journal-title":"Semin Radiat Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115003732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115003732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:58:53Z","timestamp":1537055933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115003732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0007455115003732"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.11.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancers du col ut\u00e9rin de stade IB2, IIA et IIB sans extension ganglionnaire trait\u00e9s par chimioradioth\u00e9rapie pr\u00e9op\u00e9ratoire","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}